L25. Fungicides and Antifungal Compounds III: Detailed Guide to Fungicide Resistance

Fundamentals of Fungicide Resistance

• Definition of Fungicide Resistance: This phenomenon occurs when a fungal population, previously sensitive to a specific fungicide, develops the inherited ability to survive and reproduce despite being exposed to a dose of that chemical that would normally be lethal or inhibitory. This typically involves a shift in the sensitivity of the population over time.

• Drivers of Fungicide Resistance in the Fields:

  • High frequency of fungicide application, which creates constant selection pressure.

  • Use of single-site fungicides (those with a specific mode of action target).

  • High reproductive rates and short life cycles of the fungal pathogens.

  • Vast population sizes of pathogens, increasing the likelihood of spontaneous mutations.

  • Monocultures or limited crop rotation, which provide a stable environment for resistant strains to proliferate.

Genetics and Categorization of Resistance

• De novo (Acquired) Resistance:

  • This refers to the development of resistance within a previously susceptible population. It usually occurs through spontaneous mutations in the genome or through epigenetic changes that allow the organism to survive the fungicide stress.

• Genotypic Resistance:

  • Resistance that is encoded within the DNA of the organism. This genetic trait is passed down to offspring, ensuring the longevity of the resistant phenotype in the population.

• Intrinsic Resistance & Pleiotropic Co-option:

  • Intrinsic Resistance: This is a natural, innate insensitivity to a specific fungicide that exists before any exposure. It is often due to the fungal species lacking the target site of the fungicide or having natural barriers to the chemical.

  • Pleiotropic Co-option: This involves the recruitment of existing genetic pathways, which evolved for other purposes (such as dealing with environmental toxins), to provide defense against specialized fungicides.

• Interspecific Transfer:

  • The movement of resistance genes between different species of fungi, often through horizontal gene transfer or hybridization, which can rapidly spread resistance across diverse fungal communities.

Population Dynamics of Fungicide Resistance

• Discrete or Monogenic Resistance:

  • Characterized by a single gene mutation that confers a high level of resistance.

  • The population typically exhibits a clear "all-or-nothing" response, where individuals are either completely sensitive or highly resistant.

  • This often results in a rapid and complete failure of the fungicide in the field once the resistant allele spreads.

• Gradual or Polygenic Resistance:

  • Resistance is controlled by the additive effects of multiple genes.

  • The population shows a continuous range of sensitivity levels.

  • Resistance develops slowly over time as the pathogen accumulates various mutations, leading to a "creeping" erosion of fungicide efficacy rather than a sudden crash.

Molecular Mechanisms of Fungicide Resistance

Fungi employ several sophisticated molecular strategies to survive exposure to antifungal agents:

• Active Secretion from Cells: The fungus utilizes efflux pumps to actively transport the fungicide out of the cytoplasm, keeping the internal concentration below the toxic threshold.

• Reduced Uptake: Modifications to the cell wall or plasma membrane that decrease the permeability to the fungicide, preventing it from entering the cell in significant quantities.

• Increase in Target Site Concentration: The fungus overexpresses the gene encoding the target enzyme. By producing an excess of the target, the fungus ensures that enough functional enzymes remain available even if some are inhibited by the fungicide.

• Mutations in Target Site: Structural changes in the target protein (caused by DNA mutations) alter the binding site, reducing the affinity of the fungicide for its target while maintaining the protein's biological function.

• Changes in the Biosynthetic Pathway: The fungus may bypass the inhibited step in a metabolic pathway or utilize alternative enzymes to produce essential components like ergosterol.

• Detoxification or Breakdown: The fungus produces enzymes that metabolize or degrade the fungicide molecules into non-toxic metabolites through chemical modification.

Case Study: DMI (Azole) Resistance

Resistance to Demethylation Inhibitors ($DMI$), specifically azoles, serves as a primary example of complex, polygenic resistance.

• Mechanisms of DMI Resistance:

  • Target-Site Mutations: Specific alterations in the $CYP51$ gene (encoding the enzyme sterol $14\alpha$-demethylase).

  • Overexpression of Target Site: Increasing the amount of the $CYP51$ enzyme to outcompete the inhibitor.

  • Increased Efflux: Elevated activity of transporters that move the azole out of the cell.

  • Alterations in Ergosterol Biosynthesis: Modifications in the late stages of the ergosterol pathway to prevent the accumulation of toxic sterol intermediates.

  • Aneuploidy: Changes in chromosome number (gains or losses) that can result in increased gene dosage for resistance-related genes.

Cross-Resistance and Multidrug-Resistance (MDR)

• Definition and Importance: When a fungus develops resistance to one fungicide, it may simultaneously exhibit resistance to other fungicides. This complicates disease management as it limits the rotation options for the grower.

• Types of Cross-Resistance:

  • Complete Cross-Resistance: Resistance to one drug results in an identical level of resistance to all other drugs within the same chemical class.

  • Partial Cross-Resistance: Resistance to one drug provides some level of protection against another, but the degree of resistance varies between the compounds.

  • Negative Cross-Resistance: A rare but useful phenomenon where a mutation that confers resistance to one fungicide actually increases the sensitivity of the fungus to a different fungicide.

• Cross-Resistance Between Agricultural and Medical Drugs: There is a significant concern that the use of azoles in agriculture selects for resistant strains (such as $Aspergillus\,fumigatus$) that can then cause infections in humans that are difficult to treat with medical azoles.

• Environmental Route of Antifungal and Antibiotic Resistance Development in Hospitals: Resistant pathogens or resistance genes can be selected in the environment (fields and waste) and subsequently introduced into hospital settings through food, water, or human activity, contributing to the rise of healthcare-associated infections.

• Multidrug Resistance (MDR):

  • The ability of a fungus to resist multiple, chemically unrelated fungicides simultaneously.

  • This is often mediated by the generalized activation of cellular defense systems rather than changes to a specific target site.

• MDR Transporters:

  • ATP-binding cassette (ABC) Transporters: These use the energy from $ATP$ hydrolysis to pump a wide variety of toxic substances, including fungicides, out of the cell.

  • Major Facilitator Superfamily (MFS) Transporters: These utilize the electrochemical gradient (proton motive force) across the membrane to drive the efflux of fungicides and other small molecules.